Indaptus Therapeutics, Inc.
3 Columbus Circle
15th Floor
New York, NY 10019
February 13, 2025
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
| RE: | Indaptus Therapeutics, Inc. (CIK 0001857044) | |
| Registration Statement No. 333-284863 on Form S-1 (the “Registration Statement”) |
Ladies and Gentlemen:
Indaptus Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effectiveness of the above-referenced Registration Statement pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), so that it may become effective on February 13, 2025, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by telephone call to our counsel, Greenberg Traurig, P.A., by calling Gary Emmanuel at 212-801-9337. The Company hereby authorizes Mr. Emmanuel to orally modify or withdraw this request for acceleration.
| Very truly yours, | ||
| INDAPTUS THERAPEUTICS, INC. | ||
| By: | /s/ Nir Sassi | |
Nir Sassi | ||
| Chief Financial Officer | ||